Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with Investing 4,108 headlines found


Philip Morris And Altria: Ignoring This Is A Critical Mistake

The FDA has "rejected" these claims, but that is a bit misleading and is not final. What matters is the ability to sell the product at all, and that is what investors must focus on.
Seeking Alpha blog network
added Feb 1, 2018 01:39

VIDEO: CDC Director Fitzgerald resigns

Dr. Brenda Fitzgerald, director of the US Centers for Disease Control and Prevention, resigned her position on Wednesday. The move comes one day after Politico reported Fitzgerald's purchase of tobacco stock after she assumed the position of the nation's
added Jan 31, 2018 16:12

Dr. Brenda Fitzgerald, C.D.C. Director, Resigns Over Tobacco and Other Investments

In a statement, Alex Azar, the newly appointed secretary of Health and Human Services, announced the resignation of the director, Dr. Brenda Fitzgerald, citing her “complex financial interests that have imposed a broad recusal limiting her ability to com
New York Times
added Jan 31, 2018 16:08

[Georgia] Trump's top health official traded tobacco stock while leading anti-smoking efforts

CDC Director Brenda Fitzgerald bought shares in a global tobacco giant even as her previous holdings were under review...Purchases included between $1,001 and $15,000 of Japan Tobacco, one of the largest such companies in the world, which sells four toba
added Jan 31, 2018 16:02

[New Jersey] SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Philip Morris International Inc. of Class Action Lawsuit and Upcoming Deadline - PM

Defendants made false and/or misleading statements and/or failed to disclose that: (1) there were irregularities in the clinical experiments that underpin Philip Morris' application to the U.S. Food and Drug Administration ("FDA") for approval of its iQOS
PR Newswire
added Jan 30, 2018 16:51

Did the FDA Just Doom Philip Morris International's Future?

With so much on the line for Philip Morris' future, investors will have to watch the FDA closely to see what future developments say about the prospects for iQOS in the U.S. market.
Motley Fool
added Jan 30, 2018 14:51

Americas Tobacco: TPSAC vote delays/lowers the likelihood of MRTPA approval for iQOS; PMTA approval still likely

While the FDA decision is still pending (and the TPSAC vote is not binding), we believe yesterday's votes lower the likelihood of iQOS obtaining a reduced risk claim. From a stock standpoint, we still see strong (30%) share price upside potential in PM an
Goldman Sachs Research
added Jan 27, 2018 02:54

Americas Tobacco: TPSAC Meeting Day 1: TPSAC expresses some concerns on IQOS MRTPA

PM's totality of evidence is supportive of MRTPA claim, in our view - We believe that PM has presented compelling evidence that would support the claim that IQOS leads to significantly reduced Harmful and Potentially Harmful Constituents (HPHC) productio
Goldman Sachs Research
added Jan 27, 2018 02:51

[UK] Tobacco, oil, and arms – where Imperial is investing its money

An analysis of Imperial College London’s endowment fund has revealed significant direct and indirect investments in the tobacco, fossil fuel, weapons, and pharmaceutical industries..."Even College’s commitment to avoid investing in tobacco seems paper-th
Felix-Imperial Colleges Student Newspaper
added Jan 27, 2018 02:31

How Should Investors React To FDA Rejection Of iQOS?

The headline doesn't read well, but in reality this is not yet a cause for concern over the eventual implementation of iQOS in the United States. In fact, when you consider the sum of all parts, I arrive at an overwhelming conclusion that iQOS will find
Seeking Alpha blog network
added Jan 26, 2018 12:53
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines